Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 8Neoplasms 4Overweight 2Endometrial Neoplasms 2Diabetes Mellitus, Type 2 2Stroke 1Sedentary Behavior 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteoporosis 1Motor Activity 1Kidney Diseases 1Hypertension 1Heart Failure 1Frailty 1Endometrial Hyperplasia 1Diabetes Mellitus 1Cardiovascular Diseases 1Arthritis 1

Interventions

Progestins 2semaglutide 1Tirzepatide 1Resistance Training 1Nutrition Assessment 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Hyperplasia × Resistance Training × Other × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡